December 2018 - Page 306 of 313

NYSE Companies - December 3, 2018

Suncor Énergie fait une mise à jour à la suite de la décision du gouvernement de l’Alberta de réduire la production de pétrole

CALGARY, Alberta, 03 déc. 2018 (GLOBE NEWSWIRE) — Suncor confirme aujourd’hui qu’elle évalue l’incidence de l’annonce du gouvernement de l’Alberta […]

NASDAQ Companies - December 3, 2018

Aclaris Therapeutics Closes Acquisition of RHOFADE® (oxymetazoline hydrochloride) cream, 1% from Allergan

WAYNE, Pa., Dec. 03, 2018 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, […]

NASDAQ Companies - December 3, 2018

Pluristem Presents Data from First Cohort in Ongoing Phase I Hematological Study at the American Society of Hematology (ASH) Annual Meeting

Primary safety endpoint met in first cohort with early signals of efficacy in improving blood counts Trial is progressing with […]

NASDAQ Companies - December 3, 2018

uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B

— Clinical Benefit of AMT-060 Maintained in All Patients Through up to Two and a Half Years of Follow-up – […]

NASDAQ Companies - December 3, 2018

AETI Joint Venture, BOMAY, Receives Major Order for Drilling Rig Control Systems

HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — American Electric Technologies, Inc. (NASDAQ:AETI) (the “Company”) today announced that its Chinese joint […]

NASDAQ Companies - December 3, 2018

Amyris Partners with Camil Alimentos to Deliver Zero Calorie Sweetener Made from Sugarcane to Brazilian Consumers

Agreement between the Brazilian multinational and the American company provides exclusivity for Latin America and aims to meet the growing […]

NASDAQ Companies - December 3, 2018

Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasome Inhibitor in Poster Presentation at the 60th American Society of Hematology Annual Meeting & Exposition

– Increased PD-L1 expression correlates with clinical response when pelareorep is combined with a proteasome inhibitor – – Data continue […]

NASDAQ Companies - December 3, 2018

Arcturus Therapeutics to Host a Key Opinion Leader Call on Ornithine Transcarbamylase (OTC) Deficiency on December 11

SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on […]

TSX News - December 3, 2018

Trillium Therapeutics Provides Update on its Intratumoral TTI-621 Program at the American Society of Hematology 60th Annual Meeting

TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies […]

TSX News - December 3, 2018

Bonterra Energy Corp. Confirms Cash Dividend for November 2018 Payable December 31, 2018

CALGARY, Alberta, Dec. 03, 2018 (GLOBE NEWSWIRE) — Bonterra Energy Corp. (www.bonterraenergy.com) (TSX: BNE) (“Bonterra” or the “Company”) confirms that […]